|

Caregiver Burden with Mesothelioma: Social Support and Family Resilience

ByHolly Zink
Caregiver Burden with Mesothelioma: Social Support and Family Resilience

A new study found that older or spousal caregivers of patients with lung cancer are more likely to suffer from caregiver burden.

This discovery was made by researchers in China. Their goal was to find factors related to caregiver burden in lung cancer families. They also wanted to find out if family resilience can improve caregiver burden.

Taking Care of a Loved One

Malignant mesothelioma is a highly lethal type of membrane cancer. Most mesothelioma patients lived or worked around asbestos. When mesothelioma occurs in the lungs, it is called malignant pleural mesothelioma.

There are approximately 2,000 cases of mesothelioma in the United States every year. People with mesothelioma might start to feel shortness of breath, chest pain, and weight loss.

There are limited treatment options for mesothelioma and they can be difficult. Patients often undergo many types of therapies like chemotherapy, radiation, and surgery.

The person who takes care of a patient with mesothelioma may experience caregiver burden. This is when the stress of caring for a sick person affects their physical and mental health.

Other studies have shown that having a strong support network can improve caregiver burden. A strong social support network can increase the likelihood of experiencing family resilience. Family resilience is how well a family can recover from a difficult situation.

Burden, Social Support, and Family Resilience

In this study, the researchers looked at 213 caregivers to patients with lung cancer. They used surveys to ask these caregivers about their experiences. The survey answers revealed information about caregiver burden, social support, and family resilience.

Caregivers with higher levels of social support also felt lower caregiver burden. Strong family resilience influenced this relationship.

Older caregivers experienced more caregiver burden than younger caregivers. This may be because older caregivers have more physical problems and fewer social opportunities.

Caregivers who were the spouse of the lung cancer patient also experienced higher levels of caregiver burden. They tend to carry a greater workload than non-spouse caregivers. They also feel more emotional distress than other types of caregivers.

Doctors can help the caregivers of lung cancer patients by sharing resources for social support and self-care. Older caregivers can get more help with diet and exercise options. Spousal caregivers would benefit from emotional therapies and communication strategies.

Source

Zhang Y, Ding Y, Liu C, et al. Relationships Among Perceived Social Support, Family Resilience, and Caregiver Burden in Lung Cancer Families: A Mediating Model [published online ahead of print, 2022 Nov 12]. Semin Oncol Nurs. 2022;151356. doi:10.1016/j.soncn.2022.151356

Similar Posts

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    ByAlex Strauss

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • |

    New Prognostic Factor in Peritoneal Mesothelioma

    ByAlex Strauss

    Malignant peritoneal mesothelioma is a rare form of mesothelioma that attacks the membrane that lines the abdomen and surrounds internal organs. The outlook for this rare malignancy, which affects fewer than 500 Americans annually, has been improved by the treatment combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The combination has produced 5-year overall survival rates ranging from 29% to 63%. But not all peritoneal mesothelioma patients are good candidates for CRS/HIPEC. The challenge, for clinicians, is identifying which patients are likely to benefit from the procedure (or even be cured) and which are not. In an effort to help answer that question, French researchers recently tested the prognostic value of the glucose transporter protein GLUT1 as well as…

  • |

    Mesothelioma Symptoms May Benefit from Tuberculosis Drugs

    ByAlex Strauss

    Pleural effusion is the one of most uncomfortable and life-limiting symptoms of pleural mesothelioma. The buildup of fluid in the pleural space around the lungs, which can happen in late stage mesothelioma as well as several other types of cancer, limits breathing and can be painful. Effusion is often one of the primary reasons that mesothelioma patients in the late stages of the disease have trouble taking a full breath and complain of chest pain and fatigue. While pleural fluid can be drained off through thoracentesis or chemically absorbed through pleurodesis, these treatments are painful, risky, and not always effective. Now, a team of researchers in China say they may have discovered a non-invasive method for dealing with pleural effusion caused…

  • |

    Study Lists Factors That Impact Mesothelioma Prognosis

    ByAlex Strauss

    Predicting survival in mesothelioma patients does not have to be complicated. A new Parisian study suggests that simple-to-measure factors such as patient age and the histological subtype of the mesothelioma can be highly accurate prognostic indicators. The study followed 170 patients diagnosed with malignant pleural mesothelioma between 2000 and 2010 at Saint Antoine Hospital in Paris. Patients in the study were all treated non-surgically. For each patient, a list of parameters was recorded including age, gender, tobacco use, asbestos exposure, type and duration of symptoms, BMI, C-reactive protein levels and white blood cell and platelet counts.  Inflammation of the pleura (pachypleuritis) was also noted, along with the type of diagnostic surgical procedure, histological subtype, the way in which pleurodesis was performed (for…

  • |

    Predicting Mesothelioma Outcomes with Blood Tests

    ByAlex Strauss

    Two separate teams of Japanese researchers are delving into the possibilities of blood serum indicators that could help predict outcomes in patients with malignant pleural mesothelioma. Mesothelioma is a rare but aggressive cancer caused by exposure to asbestos. Pleural mesothelioma, a cancer that starts on the lining around the lungs, is the most common form of the disease. It occurs most often in people who have inadvertently inhaled asbestos dust. Mesothelioma is highly resistant to conventional treatments. It is also difficult to predict which patients are likely to do well with standard therapies and which are not, which is referred to as prognosis. But researchers worldwide are continually searching for new ways to diagnose and predict the prognosis of patients with…

  • |

    Green Tea, Vitamin C, Chemo Fight Mesothelioma ‘Synergistically’

    ByAlex Strauss

    Another study has found that the beneficial compounds in green tea may be powerful mesothelioma fighters – especially when combined with other drugs and nutrients. Epigallocatechin gallate (EGCG) is the most abundant polyphenol in green tea and is a potent antioxidant. A number of studies have suggested that it may help the body combat various types of cancer, including mesothelioma. Recently, a group of Italian mesothelioma researchers combined EGCG with Vitamin C and a chemotherapy drug called gemcitabine to create a treatment combination called AND (Active Nutrients/Drug). To test the mixture, they administered AND to various mesothelioma cell lines in the laboratory. The result was a “synergistic cytotoxic mechanism”, meaning the ingredients in AND seemed to increase each other’s cancer-fighting properties…